According to Merck's latest financial reports the company has $37.63 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $37.63 B | -18.29% |
2022-12-31 | $46.05 B | 20.39% |
2021-12-31 | $38.25 B | 50.59% |
2020-12-31 | $25.40 B | -2.3% |
2019-12-31 | $26.00 B | -3.28% |
2018-12-31 | $26.88 B | -22.24% |
2017-12-31 | $34.56 B | -14.24% |
2016-12-31 | $40.30 B | -9.96% |
2015-12-31 | $44.76 B | -8.25% |
2014-12-31 | $48.79 B | -6.76% |
2013-12-31 | $52.32 B | -5.66% |
2012-12-31 | $55.46 B | -2.6% |
2011-12-31 | $56.94 B | 0.24% |
2010-12-31 | $56.80 B | -7.61% |
2009-12-31 | $61.48 B | 190.47% |
2008-12-31 | $21.16 B | 2.8% |
2007-12-31 | $20.59 B | 3.13% |
2006-12-31 | $19.96 B | -2.06% |
2005-12-31 | $20.38 B | 3.5% |
2004-12-31 | $19.69 B | 1.04% |
2003-12-31 | $19.49 B | -15.73% |
2002-12-31 | $23.12 B | 10.73% |
2001-12-31 | $20.88 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 82.74% | ๐บ๐ธ USA |
Novartis NVS | $46.75 B | 24.22% | ๐จ๐ญ Switzerland |
Pfizer PFE | $89.28 B | 137.25% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $38.82 B | 3.17% | ๐บ๐ธ USA |
Eli Lilly LLY | $10.86 B | -71.13% | ๐บ๐ธ USA |
Amgen AMGN | $6.23 B | -83.44% | ๐บ๐ธ USA |
Sanofi SNY | $82.20 B | 118.42% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $29.48 B | -21.66% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $16.28 B | -56.72% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $8.12 B | -78.41% | ๐ฎ๐ฑ Israel |